CA2337964A1 - Treatment of central nervous system ischemia or trauma with epidermal growth factor-like polypeptides - Google Patents
Treatment of central nervous system ischemia or trauma with epidermal growth factor-like polypeptides Download PDFInfo
- Publication number
- CA2337964A1 CA2337964A1 CA002337964A CA2337964A CA2337964A1 CA 2337964 A1 CA2337964 A1 CA 2337964A1 CA 002337964 A CA002337964 A CA 002337964A CA 2337964 A CA2337964 A CA 2337964A CA 2337964 A1 CA2337964 A1 CA 2337964A1
- Authority
- CA
- Canada
- Prior art keywords
- egf
- polypeptide
- injury
- growth factor
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9583098P | 1998-08-07 | 1998-08-07 | |
US60/095,830 | 1998-08-07 | ||
PCT/US1999/018022 WO2000007611A1 (en) | 1998-08-07 | 1999-08-06 | Treatment of central nervous system ischemia or trauma with epidermal growth factor-like polypeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2337964A1 true CA2337964A1 (en) | 2000-02-17 |
Family
ID=22253781
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002337964A Abandoned CA2337964A1 (en) | 1998-08-07 | 1999-08-06 | Treatment of central nervous system ischemia or trauma with epidermal growth factor-like polypeptides |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1100523A4 (ja) |
JP (1) | JP2002522394A (ja) |
CA (1) | CA2337964A1 (ja) |
WO (1) | WO2000007611A1 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1472375B1 (en) | 2002-01-08 | 2009-04-01 | Novartis Vaccines and Diagnostics, Inc. | Gene products differentially expressed in cancerous breast cells and their methods of use |
EP1449538A1 (en) | 2003-02-21 | 2004-08-25 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal transactivation |
WO2015134869A2 (en) * | 2014-03-06 | 2015-09-11 | Children's National Medical Center | Treatment of neonatal brain injury with hb-egf |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992006705A1 (en) * | 1990-10-16 | 1992-04-30 | The Children's Medical Center Corporation | Heparin binding mitogen with homology to epidermal growth factor (egf) |
-
1999
- 1999-08-06 JP JP2000563296A patent/JP2002522394A/ja not_active Withdrawn
- 1999-08-06 WO PCT/US1999/018022 patent/WO2000007611A1/en not_active Application Discontinuation
- 1999-08-06 EP EP99939096A patent/EP1100523A4/en not_active Withdrawn
- 1999-08-06 CA CA002337964A patent/CA2337964A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2000007611A1 (en) | 2000-02-17 |
EP1100523A1 (en) | 2001-05-23 |
JP2002522394A (ja) | 2002-07-23 |
EP1100523A4 (en) | 2005-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4847634B2 (ja) | 中枢神経系の虚血または外傷の機能的回復を増大させる方法 | |
KR100334739B1 (ko) | 절단된신경교세포주-유래신경영양성인자단백질산물 | |
IE912793A1 (en) | Chimeric neurotrophic factors | |
JP2003159083A (ja) | 新規な神経栄養因子 | |
US20110262432A1 (en) | mutated netrin 4 proteins, fragments thereof and their uses as drugs | |
JP2001513334A (ja) | ヘパリン結合増殖因子(hbgf)ポリペプチド | |
US8420780B2 (en) | Mutated netrin 4, fragments thereof and uses thereof as drugs | |
US7129054B2 (en) | Antibodies to a growth/differentiation factor of the TGF-β family | |
US6171584B1 (en) | Method of treatment with growth/differentiation factors of the TGF-β family | |
CA2337964A1 (en) | Treatment of central nervous system ischemia or trauma with epidermal growth factor-like polypeptides | |
CA2216165C (en) | Ndf peptides | |
US6080845A (en) | Monoclonal antibody against utricular epithelium | |
Stortelers | The role of EGF-like growth factors in selective ErbB receptor dimerisation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |